L-C Ligament Versus Hamstring Autograft for Primary ACL Reconstruction

Inclusion Criteria: * Patients with acute ruptures of the ACL who are willing to undergo treatment within 18 weeks of injury Exclusion Criteria: * Prior ACL reconstruction or other surgical procedure on the affected (target) knee * Chronic ACL injury; interventional surgery scheduled 127 days or more after ACL injury * Professional athletes currently engaged in active sport * Prior distal femoral and/or proximal tibial fracture(s) of the target leg * Previous or current ACL injury on contra-lateral leg * Multi-ligament reconstruction * Malalignment or varus thrust * Patient \> 193 cm tall (6' 4") * The patient does not follow pre-operative rehabilitation that may have been prescribed post-injury (prior to Index Procedure) * Confirmed connective tissue disorder * Signs of moderate to severe degenerative joint disease * Severe pain, swelling, or redness within 24 hours prior to surgery * Complete or partial Posterior Cruciate Ligament (PCL) tear * If concomitant meniscal injury is present, any of the following: 1/3rd meniscal resection; complex double-bucket tear; partially repaired meniscal tears * Any type of lateral and/or medial meniscal tear which is not repairable (\<2mm from rim) * Additional concomitant injuries to the knee or lower extremities requiring treatment, per surgeon's discretion, that are not allowable under the Inclusion criteria * The patient is unwilling to not participate in sporting activities for at least 9 months post-procedure * The patient is mentally compromised * The patient has a neuromuscular disorder that would engender unacceptable risk of knee instability, prosthesis fixation failure, or complications in postoperative care * The patient has an active or latent infection in or about the affected knee joint or an infection site distant from the knee that may spread to the knee hematogenously * Pregnant based on a positive beta hCG serum or an in vitro diagnostic test result or breast-feeding * The patient is obese with a BMI \> 35 * The patient has a known allergy to PLLA * The patient has a medical condition or comorbidity that would interfere with study participation